1. All Products
  2. DINJ - Injectable drugs
  3. CEFOTAXIME sodium, eq. 500mg base, vial
Public Pricelist

CEFOTAXIME sodium, eq. 500mg base, vial

https://medicalguidelines.msf.org/en/node/764
https://unicat.msf.org/cat/product/11649
STD DINJCEFO5V-

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
Article is intended to be used with children (<12 years) ONLY.
6.2.2 - Watch group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01DD01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

CEFOTAXIME

Therapeutic Action

Third generation cephalosporin antibacterial

Indications

In hospitalised neonates:

Bacterial meningitis, in combination with another antibacterial

Urinary infection

Pneumonia

Gonococcal conjunctivitis

Instructions for use

  • IM or slow IV injection (3 to 5 minutes): reconstitute the powder vial with 2 ml water for injection.
  • IV infusion (20 to 60 minutes): reconstitute the powder vial in 0.9% NaCl or 5% dextrose.

For pneumonia in neonates, prefer ampicillin + gentamicin.

For gonococcal conjunctivitis in neonates, use cefotaxime only if ceftriaxone is not available or contraindicated.

Storage

Below 25°C - Protect from sunlight